Palbociclib
CAS 571190-30-2
Visão geral
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy
A Anant Labs fabrica e fornece impurezas de Palbociclib de alta qualidade para o mercado global. Nossas impurezas EP de Palbociclib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Em Estoque
Palbociclib
CAS 571190-30-2Em Estoque
Dados Técnicos
CAS571190-30-2
Fórmula Mol.C24H29N7O2
Peso Mol.447.543 g/mol
IUPAC6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrido[2,3-d]pyrimidin-7-one
SMILESCC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
InChIInChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)
Chave InChIAHJRHEGDXFFMBM-UHFFFAOYSA-N
Pureza—
Sinônimos
Palbociclib571190-30-2IbrancePD-0332991PD0332991PD 03329916-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-oneG9ZF61LE7GPD 3329916-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one
